Partial complementary deoxyribonucleic acid cloning of equine relaxin messenger ribonucleic acid, and its localization within the equine placenta.
Abstract: To determine the site of relaxin gene expression in equine placentae, a set of degenerate oligonucleotide primers was made according to the published amino acid sequence of the A- and B-chain of equine relaxin (eRXN). Total cellular RNA (tcRNA) from equine placentae at about 120 and 300 days of pregnancy was subjected to reverse transcriptase-polymerase chain reaction (RT-PCR) with use of these primers. A single amplification product of approximately 430 bp was detected in each case by agarose gel electrophoresis. The PCR product was ligated into Bluescript plasmid and sequenced to confirm the identity of the clone as an eRXN cDNA fragment. Nucleic acid sequence analysis revealed a 428-bp eRXN cDNA fragment encoding for parts of the A- and B-chain and the connecting peptide (109 residues). Northern analysis of tcRNA from placentae of 120 and 300 days of pregnancy was carried out with use of antisense digoxigenin-labeled cRNA generated from the cDNA clone, and a single transcript of approximately 1 kb was detected. In situ hybridization on placental tissue at 120 and uteroplacental tissue at 300 days of pregnancy indicated that only the fetal trophoblastic cells expressed eRXN mRNA transcripts. The identity of these cells was confirmed by their positive staining with an antibody specific for equine trophoblast (cell surface) protein. Relaxin peptide was also detected immunohistochemically in samples of the same placental tissues. This is the first report of the nucleic acid sequence of eRXN. The study identified fetal trophoblast cells as the site of eRXN mRNA expression and protein secretion in the equine placenta.
Publication Date: 1995-06-01 PubMed ID: 7543295DOI: 10.1095/biolreprod52.6.1307Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research article discusses a process to identify the location of relaxin gene expression in equine placentae. They used specific primers and various other tools to analyse RNA from the placentae at different stages of pregnancy, confirming that the relaxin gene was expressed in the fetal trophoblast cells.
Research Process
The research employed a multi-step process to determine the location of relaxin gene expression in equine placentae:
- A set of degenerate oligonucleotide primers was created in accordance with the known amino acid sequence of the equine relaxin (eRXN).
- Total cellular RNA (tcRNA) from equine placentae at approximately 120 and 300 days of gestation was subjected to reverse transcriptase-polymerase chain reaction (RT-PCR) using these primers.
- The amplified PCR output was detected through gel electrophoresis, which showed a single product of approximately 430 base pairs (bp) in each instance.
Confirmation of Cloned cDNA Fragment
- This PCR product was then ligated into a Bluescript plasmid and sequenced to verify the identity of the clone as an eRXN complementary DNA (cDNA) fragment.
- Nucleic acid sequence analysis further revealed this cloned fragment, measuring 428 bp, as an eRXN cDNA fragment that encoded parts of the A- and B-chain along with the connecting peptide (109 residues).
Use of Northern Analysis and In Situ Hybridization
- A northern analysis of tcRNA from placentae at 120 and 300 days of gestation was carried out using antisense digoxigenin-labeled cRNA generated from the cDNA clone; a single transcript of approximately 1 kilobase (kb) was found.
- In situ hybridization on placental tissue at 120 days and uteroplacental tissue at 300 days of gestation indicated that only the fetal trophoblastic cells expressed eRXN mRNA transcripts.
- The identity of these cells was confirmed with their positive staining with an antibody specific for equine trophoblast (cell surface) protein. The relaxin peptide was also detected in samples of the same placental tissues through immunohistochemical analysis.
Key Findings
- This study is the first to report the nucleic acid sequence of eRXN.
- Fetal trophoblast cells were identified as the site of eRXN mRNA expression and protein secretion in the equine placenta.
Cite This Article
APA
Klonisch T, Ryan PL, Yamashiro S, Porter DG.
(1995).
Partial complementary deoxyribonucleic acid cloning of equine relaxin messenger ribonucleic acid, and its localization within the equine placenta.
Biol Reprod, 52(6), 1307-1315.
https://doi.org/10.1095/biolreprod52.6.1307 Publication
Researcher Affiliations
- Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Canada.
MeSH Terms
- Amino Acid Sequence
- Animals
- Base Sequence
- Blotting, Northern
- Cloning, Molecular
- DNA Primers
- DNA, Complementary / chemistry
- DNA, Complementary / genetics
- Female
- Horses
- Immunohistochemistry
- In Situ Hybridization
- Molecular Sequence Data
- Placenta / chemistry
- Polymerase Chain Reaction
- Pregnancy
- RNA Probes
- RNA, Messenger / analysis
- RNA, Messenger / genetics
- RNA-Directed DNA Polymerase
- Relaxin / chemistry
- Relaxin / genetics
- Restriction Mapping
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
